[Increased serum CA 19.9 in bronchiectasis]

Rev Mal Respir. 2008 Jan;25(1):78-81. doi: 10.1016/s0761-8425(08)70471-6.
[Article in French]

Abstract

Introduction: CA 19.9 is considered the most specific and sensitive serological marker of pancreatic adenocarcinoma. However, serum CA 19.9 can be raised in several non-neoplastic disorders, particularly in various benign pulmonary diseases. An increase in serum CA 19.9 in bronchiectasis remains exceptional.

Case report: We report the case of a 67 year old woman in whom a serum level of more than 1500 U/ml (normal value less than 37 U/ml) was found incidentally. Exhaustive investigation and clinical evolution excluded a neoplastic digestive disorder but positron emission tomography revealed a distinct hypermetabolic focus in the area of the hilum of the right lung. A complementary work-up (CT scan and fibreoptic bronchoscopy) demonstrated bilateral bronchiectasis colonised with Haemophilus influenzae. Antibiotic therapy with amoxicillin-clavulanic acid brought about a decrease in the serum CA 19.9 but level of the tumour marker remained abnormal after more than 2 years.

Conclusion: This case report emphasises the uselessness of tumour markers as screening tests as a serum level of CA 19.9 up to 50 times normal may be found in benign respiratory disorders such as bronchiectasis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biomarkers / blood
  • Bronchiectasis / diagnosis*
  • Bronchiectasis / immunology
  • Bronchiectasis / microbiology
  • CA-19-9 Antigen / blood*
  • Female
  • Haemophilus Infections / diagnosis
  • Haemophilus Infections / immunology
  • Haemophilus influenzae / immunology
  • Haemophilus influenzae / isolation & purification
  • Humans

Substances

  • Biomarkers
  • CA-19-9 Antigen